Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients.

MLA

Barbanti, Piero, et al. “Predictors of Response to Anti-CGRP Monoclonal Antibodies: A 24-Week, Multicenter, Prospective Study on 864 Migraine Patients.” The Journal of Headache and Pain, vol. 23, no. 1, Nov. 2022, p. 138. EBSCOhost, https://doi.org/10.1186/s10194-022-01498-6.

APA

Barbanti, P., Egeo, G., Aurilia, C., Altamura, C., d’Onofrio, F., Finocchi, C., Albanese, M., Aguggia, M., Rao, R., Zucco, M., Frediani, F., Filippi, M., Messina, R., Cevoli, S., Carnevale, A., Fiorentini, G., Messina, S., Bono, F., Torelli, P., … Vernieri, F. (2022). Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients. The Journal of Headache and Pain, 23(1), 138. https://doi.org/10.1186/s10194-022-01498-6

Chicago

Barbanti, Piero, Gabriella Egeo, Cinzia Aurilia, Claudia Altamura, Florindo d’Onofrio, Cinzia Finocchi, Maria Albanese, et al. 2022. “Predictors of Response to Anti-CGRP Monoclonal Antibodies: A 24-Week, Multicenter, Prospective Study on 864 Migraine Patients.” The Journal of Headache and Pain 23 (1): 138. doi:10.1186/s10194-022-01498-6.